Today, the Governments of Canada and the province of Saskatchewan signed the National Strategy for Drugs for Rare Disease (DRD) agreement to invest over $40 million over three years to improve access to new drugs for rare diseases for Saskatchewan residents and to support enhanced access to existing drugs, early diagnosis, and screening for rare diseases.